Cover Image

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	María A. Rodríguez‐Santiago, Valerie Wojna, Eric Miranda‐Valentín, Steven Arnold, Vanessa Sepúlveda‐Rivera
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real‐world use of diagnostic tests for mild cognitive impairment, Alzheimer's disease, and other dementias in Medicare fee‐for‐service beneficiaries
by: Jessie T. Yan, et al.
Published: (2025)

Validation of regression‐based change formulae for mild cognitive impairment and Alzheimer's disease
by: Kevin Duff, et al.
Published: (2024)

Eye tracking as a diagnostic tool in Alzheimer's disease, mild cognitive impairment, and related dementias: a systematic review
by: Gustavo Luis Verón, et al.
Published: (2025)

Utilizing deep learning to predict Alzheimer's disease and mild cognitive impairment with optical coherence tomography
by: Jacqueline Chua, et al.
Published: (2025)

Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis
by: Sunu Mathew, et al.
Published: (2025)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
by: Juliana N. Souza‐Talarico, et al.
Published: (2025)

Identifying cognitive test scores associated with early tau burden in Alzheimer's disease
by: Caitlin M. Terao, et al.
Published: (2025)

Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
by: Rachel R. Jin, et al.
Published: (2025)

Non‐Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism
by: Sebastiaan De Keersmaecker, et al.
Published: (2024)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
by: Sofia Toniolo, et al.
Published: (2024)

Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment
by: Marieclaire Overton, et al.
Published: (2025)

Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease
by: Miguel Ángel Rivas‐Fernández, et al.
Published: (2026)

Alzheimer's disease cerebrospinal fluid biomarkers and kidney function in normal and cognitively impaired older adults
by: Ihab Hajjar, et al.
Published: (2024)

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
by: Yuhan Xie, et al.
Published: (2025)

Longitudinal changes in functional capacity in frontotemporal dementia and Alzheimer's disease
by: David Foxe, et al.
Published: (2024)

Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia
by: Adam H. Dyer, et al.
Published: (2025)

Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
by: Darren M. Lipnicki, et al.
Published: (2026)

Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
by: Willa D. Brenowitz, et al.
Published: (2026)

Alzheimer's disease neuropathology and longitudinal change in subjective cognitive complaints
by: Alisa Bannerjee, et al.
Published: (2025)

Cerebrospinal fluid sclerostin levels in the early Alzheimer's disease stages
by: Manuela Dicarlo, et al.
Published: (2026)

Brain‐derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia
by: Cassandra Marotta, et al.
Published: (2025)

Multilevel prediction of Alzheimer's disease dementia in the United States: An artificial intelligence analysis
by: Nicolaas P. Pronk, et al.
Published: (2026)

Vocal expression of emotions discriminates dementia with Lewy bodies from Alzheimer's disease
by: Masatomo Kobayashi, et al.
Published: (2024)

Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
by: Ying Xia, et al.
Published: (2025)

Temporal comorbidity patterns in Alzheimer's disease and vascular dementia: A population‐based observational study in UK Biobank
by: Chloe Walsh, et al.
Published: (2026)

Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia
by: Iolanda Lázaro, et al.
Published: (2024)

Caregivers’ attitudes toward blood‐based biomarker testing for Alzheimer's disease
by: Katharina Bolsewig, et al.
Published: (2024)

Machine learning models of Alzheimer's disease spectrum using blood tests
by: Nicola Walter Falasca, et al.
Published: (2025)

Mid‐ and late‐life depression increases risk of Alzheimer's disease and related dementias in veterans
by: Lay Kodama, et al.
Published: (2026)

Examining the propensity and nature of criminal risk behaviours in frontotemporal dementia syndromes and Alzheimer's disease
by: Fiona Kumfor, et al.
Published: (2024)

α‐Synuclein seed amplification assay in Lewy body dementia versus Alzheimer's disease
by: Oskar H. McWilliam, et al.
Published: (2025)

Microstructural alterations in the locus coeruleus‐entorhinal cortex pathway in Alzheimer's disease and frontotemporal dementia
by: Giulia Quattrini, et al.
Published: (2024)

Divergent effects of age on imaging‐based ATN biomarkers and cognition in Alzheimer's disease
by: Lars Frings, et al.
Published: (2025)

Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline
by: Stefan J. Teipel, et al.
Published: (2024)

Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome
by: Emily K. Schworer, et al.
Published: (2024)

Plasma lipid metabolites as biomarkers of early white matter degeneration in Alzheimer's disease
by: Alireza Shaabanpoor Haghighi, et al.
Published: (2025)

Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology
by: Lara Blömeke, et al.
Published: (2024)

Alzheimer's and dementia: Diagnosis, assessment, and disease monitoring global, regional, and national burden of Alzheimer's disease and other dementias (ADODs) and their risk factors, 1990–2021: A systematic analysis for the Global Burden of Disease study 2021
by: Fang Wang, et al.
Published: (2025)

Correction to "Plasma lipid metabolites as biomarkers of early white matter degeneration in Alzheimer's disease"
Published: (2025)

Correction to “Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology”
Published: (2024)